Whipplewood Advisors, LLC Organon & Co. Transaction History

Whipplewood Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$8.04 - $14.72 $1,013 - $1,854	126 Added 3150.0%	130 $1.26 Million
Q1 2025 Apr 09, 2025	SELL	$14.29 - $16.41 $1,900 - $2,182	-133 Reduced 97.08%	4 $2.04 Million
Q4 2024 Feb 04, 2025	BUY	$14.44 - $18.83 $1,978 - $2,579	137 New	137 $2.04 Million

791

197M

2.5M

2.94M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.92B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Whipplewood Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Whipplewood Advisors, LLC with notifications on news.